Global Veterinary Anthrax Vaccines Market Growth 2025-2031
Description
The global Veterinary Anthrax Vaccines market size is predicted to grow from US$ 39.8 million in 2025 to US$ 62.7 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 104%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Anthrax Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Anthrax Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Anthrax Vaccines sales for 2025 through 2031. With Veterinary Anthrax Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Anthrax Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Anthrax Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Anthrax Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Anthrax Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Anthrax Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Anthrax Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cell Free PA Vaccines
Live Vaccines
Segmentation by Application:
Cow
Sheep
Swine
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Anthrax Vaccines market?
What factors are driving Veterinary Anthrax Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Anthrax Vaccines market opportunities vary by end market size?
How does Veterinary Anthrax Vaccines break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 104%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Anthrax Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary Anthrax Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Anthrax Vaccines sales for 2025 through 2031. With Veterinary Anthrax Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Anthrax Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Anthrax Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Anthrax Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Anthrax Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Anthrax Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Anthrax Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Cell Free PA Vaccines
Live Vaccines
Segmentation by Application:
Cow
Sheep
Swine
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Agrovet
Bayer Sanidad Animal
Biogenesis Bago SA
Botswana Vaccine Institute
Central Veterinary Control and Research Institute
Centro Diagnostico Veterinario
Ceva Sante Animale
Colorado Serum Company
Empresa Colombiana de Productos Veterinarios S.A
Indian Immunologicals Limited
Institute for Biological Products
Intervac (PVT) Ltd
JOVAC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary Anthrax Vaccines market?
What factors are driving Veterinary Anthrax Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Anthrax Vaccines market opportunities vary by end market size?
How does Veterinary Anthrax Vaccines break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Veterinary Anthrax Vaccines by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Veterinary Anthrax Vaccines by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
